BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23866353)

  • 1. Phosphate-containing eye drops: corneal opacity.
    Prescrire Int; 2013 Jun; 22(139):154. PubMed ID: 23866353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal calcification after chemical eye burns caused by eye drops containing phosphate buffer.
    Kompa S; Redbrake C; Dunkel B; Weber A; Schrage N
    Burns; 2006 Sep; 32(6):744-7. PubMed ID: 16835011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal calcification after chemical eye burns caused by eye drops containing phosphate buffer.
    Brandslund I; Damgaard AL
    Burns; 2008 Dec; 34(8):1215. PubMed ID: 18674864
    [No Abstract]   [Full Text] [Related]  

  • 4. Corneal calcification after amniotic membrane transplantation.
    Anderson SB; de Souza RF; Hofmann-Rummelt C; Seitz B
    Br J Ophthalmol; 2003 May; 87(5):587-91. PubMed ID: 12714401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing the composition of buffered eye-drops prevents undesired side effects.
    Schrage NF; Frentz M; Reim M
    Br J Ophthalmol; 2010 Nov; 94(11):1519-22. PubMed ID: 20650912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phosphate in ophthalmologic solutions].
    Bernauer W; Thiel MA; Rentsch KM
    Ophthalmologe; 2006 May; 103(5):416-7. PubMed ID: 16622640
    [No Abstract]   [Full Text] [Related]  

  • 7. Corneal calcification and phosphates: do you need to prescribe phosphate free?
    Popiela MZ; Hawksworth N
    J Ocul Pharmacol Ther; 2014 Dec; 30(10):800-2. PubMed ID: 25244111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Be aware of toxicity of eye drops to ocular surface].
    Yan XM
    Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):387-9. PubMed ID: 15938798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial Keratitis with Lipid Keratopathy Mimicking Corneal Opacity Induced by Brimonidine Tartrate Eye Drops.
    Kasuya Y; Sano I; Makino S
    Klin Monbl Augenheilkd; 2020 Dec; 237(12):1466-1467. PubMed ID: 33285590
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recurring endothelial opacity following keratoplasty].
    Steppat MH; Müller M; Geerling G
    Ophthalmologe; 2004 Nov; 101(11):1126-8. PubMed ID: 15108015
    [No Abstract]   [Full Text] [Related]  

  • 11. Autologous serum eye drops for treating persistent corneal epithelial defect after vitreoretinal surgery.
    Huang WC; Chiang CC; Tsai YY
    Cornea; 2008 Oct; 27(9):1097; author reply 1097-8. PubMed ID: 18812784
    [No Abstract]   [Full Text] [Related]  

  • 12. Corneal calcification following intensified treatment with sodium hyaluronate artificial tears.
    Bernauer W; Thiel MA; Kurrer M; Heiligenhaus A; Rentsch KM; Schmitt A; Heinz C; Yanar A
    Br J Ophthalmol; 2006 Mar; 90(3):285-8. PubMed ID: 16488945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal staining after treatment with topical tetracycline.
    Lapid-Gortzak R; Nieuwendaal CP; Slomovic AR; Spanjaard L
    Cornea; 2006 Sep; 25(8):969-70. PubMed ID: 17102677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
    Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
    Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open clinical study of eye drops containing the fibronectin-derived peptide PHSRN for treatment of persistent corneal epithelial defects.
    Yamada N; Morishige N; Yanai R; Morita Y; Kimura K; Chikama T; Nomizu M; Sonoda KH; Nishida T
    Cornea; 2012 Dec; 31(12):1408-13. PubMed ID: 23135532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of corneal blindness: a multi-center retrospective review.
    Prabhasawat P; Trethipwanit KO; Prakairungthong N; Narenpitak S; Jaruroteskulchai S; Anantachai J
    J Med Assoc Thai; 2007 Dec; 90(12):2651-7. PubMed ID: 18386716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dangerous ophthalmic preparations.
    S Afr Med J; 1977 Jul; 52(3):101. PubMed ID: 897861
    [No Abstract]   [Full Text] [Related]  

  • 18. D-beta-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board.
    Nakamura S; Shibuya M; Nakashima H; Imagawa T; Uehara M; Tsubota K
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2379-87. PubMed ID: 15980225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal deposits in cornea from the use of vitamin C eye drops.
    Choong YY; Arumugam G
    Med J Malaysia; 1999 Dec; 54(4):526-7. PubMed ID: 11072476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcareous corneal degeneration: report of two cases.
    Lavid FJ; Herreras JM; Calonge M; Saornil MA; Aguirre C
    Cornea; 1995 Jan; 14(1):97-102. PubMed ID: 7712745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.